Jove
Visualize
Contact Us

Related Experiment Videos

Pharmacologic interventions in resuscitation.

S C Boike, M J Rybak

    Emergency Medicine Clinics of North America
    |December 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections.

    Antimicrobial agents and chemotherapy·2019
    Same author

    Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.

    Antimicrobial agents and chemotherapy·2017
    Same author

    Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis.

    Antimicrobial agents and chemotherapy·2014
    Same author

    Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA.

    Antimicrobial agents and chemotherapy·2013
    Same author

    Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2013
    Same author

    Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistant Staphylococcus aureus: case report and review of the literature.

    Transplant infectious disease : an official journal of the Transplantation Society·2012
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    This review examines how medications can prevent cardiac arrest by treating conditions like irregular heartbeats and low blood pressure. It focuses on the practical use of these pharmacologic agents during resuscitation efforts.

    Area of Science:

    • Cardiology
    • Emergency Medicine
    • Pharmacology

    Background:

    • Cardiac arrest is often preceded by critical conditions such as dysrhythmias, hypotension, shock, and anoxia.
    • Pharmacologic interventions are crucial for managing these pre-arrest states.

    Purpose of the Study:

    • To review the clinical application of specific pharmacologic agents in resuscitation.
    • To provide an overview of the use of medications in preventing cardiac arrest progression.

    Main Methods:

    • Literature review of clinical applications of pharmacologic agents in resuscitation.
    • Analysis of the role of specific drugs in managing conditions leading to cardiac arrest.

    Main Results:

    • Pharmacologic agents play a vital role in stabilizing patients with conditions predisposing to cardiac arrest.

    Related Experiment Videos

  • Specific agents are effective in managing dysrhythmias, hypotension, shock, and anoxia during resuscitation.

    • Conclusions:

    • Effective use of pharmacologic agents is essential for improving outcomes in cardiac arrest resuscitation.
    • Understanding the clinical application of these agents enhances resuscitation protocols.